Valuation : Winston Pharmaceuticals, Inc.

Market Cap	15.48M 13.34M 12.63M 11.45M 21.48M 1.48B 21.59M 150M 57.69M 752M 58.14M 56.87M 2.38B	P/E 2008	-49.9x	P/E 2009	-6.46x
Enterprise Value	13.92M 11.99M 11.36M 10.29M 19.31M 1.33B 19.41M 135M 51.86M 677M 52.27M 51.13M 2.14B	EV / Sales 2008	572x	EV / Sales 2009	14.4x
Free-Float	100%	Yield 2008 *	-	Yield 2009	-

* Estimated data More valuation ratios

Latest news : Winston Pharmaceuticals, Inc.

12-04-09

Winston Pharmaceuticals, Inc. Receives SBIR Grant from the NIH to Investigate Treatment for Postherpetic Neuralgia of the Trigeminal Nerve

More news

Managers and Directors : Winston Pharmaceuticals, Inc.

Manager	Title	Age	Since
Joel E. Bernstein CEO	Chief Executive Officer	83	2010-02-18

More insiders

Winston Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company discovers, develops and commercializes therapeutics for managing and alleviating pain. The Company's late stage candidates include products for the treatment of episodic cluster headache, chronic migraine headache, osteoarthritis, rheumatoid arthritis, neuropathic pain, and pain and inflammation in inflammatory bowel disease. The Company is developing Civamide, which is a transient receptor potential channels vanilloid-1 (TRPV-1) modulator in different dosage forms for several different pain indications. The Company's other products are under development for the treatment of headache and neuropathic and rheumatological pain.

Employees

Sector

Pharmaceuticals

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - OTC Markets 13:20:26 2023-07-12 EDT			5-day change	1st Jan Change
0.0900 ^USD	-70.00%		+8,999,900.00%	+89,900.00%

1 day	-70.00%
1 week	+8,999,900.00%
Current month	+8,999,900.00%
1 month	+8,999,900.00%
3 months	+8,999,900.00%
6 months	+89,900.00%
Current year	+89,900.00%

Current year	0		0.29
1 year	0		0.29
3 years	0		0.29
5 years	0		0.3
10 years	0		0.3

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WINSTON PHARMACEUTICALS, INC.	-70.00%	+8,999,900.00%	+89,900.00%	-.--%	77
ELI LILLY AND COMPANY	-0.65%	-2.93%	+47.70%	+86.17%	994B
JOHNSON & JOHNSON	-0.29%	-3.51%	+49.15%	+62.35%	640B
ABBVIE INC.	+0.83%	+0.26%	+17.76%	+72.25%	454B
ROCHE HOLDING AG	-0.38%	-3.59%	+30.13%	+35.17%	337B
NOVARTIS AG	-0.09%	-13.54%	+13.34%	+24.95%	261B
ASTRAZENECA PLC	-0.43%	-2.48%	-0.73%	+9.58%	246B
AMGEN INC.	-1.34%	-13.70%	+36.53%	+44.96%	204B
NOVO NORDISK A/S	-3.44%	-7.51%	-20.63%	-59.44%	190B
GILEAD SCIENCES, INC.	-0.75%	-4.82%	+25.46%	+87.14%	178B
Average	-7.65%	-5.18%	+9,009.87%	+36.31%	350.48B
Weighted average by Cap.	-0.51%	-4.42%	+30.96%	+54.95%

	2008	2009
Net sales	453K 390K 369K 335K 628K 43.23M 631K 4.38M 1.69M 22M 1.7M 1.66M 69.5M	1.39M 1.2M 1.14M 1.03M 1.93M 133M 1.94M 13.51M 5.2M 67.78M 5.24M 5.12M 214M
Net income	-5.14M -4.43M -4.19M -3.8M -7.13M -491M -7.17M -49.82M -19.16M -250M -19.31M -18.89M -790M	-2.66M -2.29M -2.17M -1.96M -3.68M -254M -3.7M -25.73M -9.89M -129M -9.97M -9.75M -408M
Net Debt	-5.63M -4.85M -4.59M -4.16M -7.81M -538M -7.85M -54.52M -20.97M -273M -21.13M -20.67M -864M	-1.56M -1.35M -1.28M -1.16M -2.17M -149M -2.18M -15.14M -5.82M -75.96M -5.87M -5.74M -240M

Winston Pharmaceuticals, Inc. Stock

Stocks

WPHM

US9756571074

Pharmaceuticals

Valuation : Winston Pharmaceuticals, Inc.

Latest news : Winston Pharmaceuticals, Inc.

Quotes and Performance

Price Extremes

Managers and Directors : Winston Pharmaceuticals, Inc.

Other Pharmaceuticals

Financials

Company Profile